Eximias Pharmaceutical Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Eximias Pharmaceutical Corporation - overview
Established
1998
Location
Berwyn, PA, US
Primary Industry
Pharmaceuticals
About
Eximias Pharmaceuticals is a pharmaceuticals company developing late stage cancer therapeutics.
Current Investors
BioAsia Investments, New York Life Investment Management, EJ Financial Enterprises
Primary Industry
Pharmaceuticals
Sub Industries
Oncology/Cancer Treatment, Pharmaceuticals
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Eximias Pharmaceutical Corporation - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.